查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球自動機械心肺復甦設備市場 - 2023-2030
市場調查報告書
商品編碼
1373392

全球自動機械心肺復甦設備市場 - 2023-2030

Global Automatic Mechanical Cardiopulmonary Resuscitation Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

機械心肺復甦術 (mCPR) 設備為心臟驟停 (SCA) 患者和其他病症患者提供自動胸外按壓。這些設備的開發是為了實現自主循環（ROSC）的恢復，合理的例如手動心肺復甦術。然而，手動心肺復甦術容易出現人為錯誤和疲勞，而機械心肺復甦術幾乎不需要人際關係，並且可以持續提供不變的高品質心肺復甦術。

因此，mCPR 設備擴大與手動 CPR 結合使用。 EMS 團隊發現這項技術特別有利，因為自動、高品質的胸外按壓為救援人員提供了時間來評估和治療患者情況的進一步細節。此外，它還為移動救護車中的手動心肺復甦術提供了安全實用的選擇。

市場動態：促進因素與限制因素

心血管疾病的高盛行率

據估計，心血管疾病的高盛行率將在預測期內增加對自動機械心肺復甦術設備的需求。例如，根據英國心臟協會 2023 年報告，據估計，全球每 13 個人中就有 1 人患有心臟或循環系統疾病，全世界約有 6.2 億人患有心臟和循環系統疾病，這個數字是由於生活方式的改變、人口老化和人口成長以及心臟病和中風的生存率提高，這一趨勢將持續成長，如果這些趨勢持續下去，預計該趨勢將持續成長。

此外，2021年6月，根據世界衛生組織估計，2020年有1,790萬人死於心血管疾病，佔所有跨國死亡人數的32%，其中超過85%是由於心臟病和中風。超過四分之三的心血管疾病死亡發生在孟加拉、阿富汗等中低收入國家。2020 年，因非傳染性疾病導致的 1700 萬人過早死亡（70 歲以下）中，超過 38% 是由於CVD。此外，不斷提高的意識、進步和市場發展等預計將有助於預測期內全球市場的成長。

設備成本高

自動機械心肺復甦設備的高成本預計將阻礙預測期內的全球市場成長。例如，自動 CPR 設備的平均成本為 10,000 美元。阻礙全球市場成長的其他因素包括缺乏熟練的專業人員和高昂的開發成本。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按設備類型分類
  • 電源片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 心血管疾病的高盛行率
    • 限制
      • 設備成本高
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 專利分析
  • 科技趨勢
  • 流行病學
  • SWOT分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按裝置類型

  • 活塞裝置
  • 負載分配裝置
  • 3D設備

第 8 章：按電源

  • 氣動驅動
  • 電池驅動
  • 機械驅動和電池驅動

第 9 章：最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心 (ASC)
  • 緊急醫療服務（EMS）
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • ZOLL Medical Corporation
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Michigan Instruments
  • Stryker
  • CPR Medical Devices, Inc.
  • Asahi Kasei Corporation
  • Defibtech LLC
  • Yantai Wanli Medical Equipment CO.,Ltd.
  • Schiller Healthcare
  • Sunlife Science
  • Ambulanc (Shenzhen) Tech.Co., Ltd.

第 13 章：附錄

簡介目錄
Product Code: MD7160

Overview

Mechanical cardiopulmonary resuscitation (mCPR) devices deliver automated chest compressions to sudden cardiac arrest (SCA) sufferers and other conditions. These devices are developed to accomplish the recovery of spontaneous circulation (ROSC), reasonable such as manual CPR. Nevertheless, while manual CPR is subject to human blunder and exhaustion, mechanical CPR demands little human relations and can provide invariant high-quality CPR continuously.

Therefore, mCPR devices are increasingly being utilized in conjunction with manual CPR. EMS teams have encountered this technology specifically advantageous as the automated, high-quality chest compressions provide rescuers time to evaluate and treat further elements of the patient's situation. Further, it delivers a secure and practical option for manual CPR in a moving ambulance.

Market Dynamics: Drivers & Restraints

High Prevalence of Cardiovascular Disorders

The high prevalence of cardiovascular disorders is estimated to boost demand for automatic mechanical cardiopulmonary resuscitation devices during the forecast period. For instance, according to the British Heart Association Report 2023, worldwide it is assessed that 1 out of 13 individuals are living with a cardiac or circulatory disorder and about 620 million individuals are living with heart and circulatory diseases all over the world, this number is growing owing to altering lifestyles, an aging, and growing inhabitants, and enhanced survival rates from heart attacks and strokes and is expected to persist to advance if these tendencies persist.

Moreover, in June 2021, according to the World Health Organization, an assessed 17.9 million individuals died from CVDs in 2020, symbolizing 32% of all multinational casualties out of these deaths, over 85% were because of heart attack and stroke. More than three-quarters of CVD deaths surface in low and middle-income nations like Bangladesh, Afghanistan etc. Among the 17 million premature casualties (under the age of 70) owing to non-communicable conditions in 2020, over 38% were because of CVDs. Furthermore, growing awareness, advancements and market developments among others are expected to contribute to the global market growth during the forecast period.

High Device Cost

The high cost of automatic mechanical cardiopulmonary resuscitation devices is expected to hamper the global market growth during the forecast period. For instance, the average cost of an automated CPR device is US$ 10,000. Other factors hampering the global market growth include the deficiency of skilled professionals and high development costs.

Segment Analysis

The global automatic mechanical cardiopulmonary resuscitation devices market is segmented based on device type, power source, end user and region.

Battery-Driven CPR Devices Segment is Expected to Dominate Market

Owing to the increasing adoption of portable battery-powered automated CPR devices is expected to boost the battery-driven CPR devices market growth, dominating the global market during the forecast period. For instance, in November 2021, Horizon Health paramedics had a new, high-tech option to aid them in rescuing lives. Cardiac chest compressions that were earlier done manually, can currently be accomplished hands-free with the touch of a switch. The Horizon Health Foundation of East Central Illinois recently granted two automated CPR devices, known as AutoPulse. They are in expansion to the two AutoPulses properly in usage by the ambulance service.

Moreover, in March 2023, with a $121,835 federal grant to be used for the procurement of cardiopulmonary resuscitation (CPR) compression devices the East Haven Fire Department (EHFD) is hoping to rescue more additional lives thanks to the grant awarded via the Assistance to Firefighters Grant (AFG) program, which is part of the Federal Emergency Management Agency (FEMA). The $122,000 grant intends to supply the department with compression devices to be part of each of its unit's apparatuses that could eliminate hindrances to manually-performed CPR for those suffering from cardiac arrests and save more lives.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the growing cases of cardiovascular diseases, increasing efforts to raise awareness and market developments boosted the North America market growth thereby holding the majority of global market share. For instance, according to the Centers for Disease Control and Prevention, approximately 695,000 individuals in the U.S. died because of heart disorders in 2021 making up for 1 out of every 5 deaths.

Moreover, in May 2023, the American Heart Association executed the 49th Emergency Medical Services (EMS) Week, which delivered awareness to the cardiovascular patients regarding the CPR devices techniques. Furthermore, in April 2023, Defibtech, a U.S. manufacturer of life-saving medical tools, introduced the next evolution of their automated CPR device, the ARM XR. The ARM XR is planned for usage by emergency medical specialists to treat patients who are in cardiac arrest.

COVID-19 Impact Analysis:

COVID-19 has positively impacted the global automated mechanical CPR devices market as during the pandemic there was an increased need to deliver CPR to patients and a deficiency of professionals which in turn increased the demand for automated mechanical CPR devices. Moreover, increased demand and guideline constraints led to the development of advanced devices requiring minimal human interaction averting the risk of infection spread.

For instance, in March 2021, NHS Tayside-a Health Board and InnoScot Health, a healthcare corporation, united to design and create the device SARUS-CPR hood that was positioned to revolutionize the resuscitation approach for first responders. SARUS-CPR hood was adopted into clinical practice by NHS Tayside following its development in reaction to the COVID-19 pandemic.

Key Developments

  • In February 2022, CPR Therapeutics Inc., a medical device company obtained a U.S. patent for another element of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: "Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems".
  • In September 2022, CPR Therapeutics Inc., a medical device company acquired a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project "A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.".

Competitive Landscape

The major global players in the market include: ZOLL Medical Corporation, Michigan Instruments, Stryker, CPR Medical Devices, Inc., Asahi Kasei Corporation, Defibtech LLC, Yantai Wanli Medical Equipment Co., Ltd., Schiller Healthcare, Ambulanc (Shenzhen) Tech.Co., Ltd. And Sunlife Science among others.

Why Purchase the Report?

  • To visualize the global automatic mechanical cardiopulmonary resuscitation devices market segmentation based on device type, power source, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of automatic mechanical cardiopulmonary resuscitation devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global automatic mechanical cardiopulmonary resuscitation devices market report would provide approximately 61 tables, 59 figures and 186 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Power Source
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. High Prevalence of Cardiovascular Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Device Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. Technology Trend
  • 5.8. Epidemiology
  • 5.9. SWOT Analysis
  • 5.10. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Piston Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Load Distribution Devices
  • 7.4. 3D Devices

8. By Power Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 8.1.2. Market Attractiveness Index, By Power Source
  • 8.2. Pneumatically Driven*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Battery Driven
  • 8.4. Mechanically Actuated and Battery-Driven

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospital*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers (ASCs)
  • 9.5. Emergency Medical Service (EMS)
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ZOLL Medical Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Michigan Instruments
  • 12.3. Stryker
  • 12.4. CPR Medical Devices, Inc.
  • 12.5. Asahi Kasei Corporation
  • 12.6. Defibtech LLC
  • 12.7. Yantai Wanli Medical Equipment CO.,Ltd.
  • 12.8. Schiller Healthcare
  • 12.9. Sunlife Science
  • 12.10. Ambulanc (Shenzhen) Tech.Co., Ltd.

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us